Botulinum toxin (BoNT)
What is it: Injectable therapy that relaxes overactive muscles by blocking nerve signals.AKA: Botox, Botulinum Neurotoxin, BTX, Dysport, Myobloc, Xeomin- ⬤ Minimal research: Very little scientific study exists, with no or very few peer-reviewed studies. Insufficient data for conclusions.
- ⬤⬤ Limited research: Few studies exist, mostly small trials or case reports. Findings are preliminary and lack strong validation.
- ⬤⬤⬤ Moderately researched: Multiple studies, including mid-sized trials, exist. Some findings are replicated, but more research is needed.
- ⬤⬤⬤⬤ Well-researched: Supported by substantial evidence, including at least one large trial or meta-analysis.
- ⬤⬤⬤⬤⬤ Extensively studied: Numerous large studies and meta-analyses exist. Findings are widely accepted with strong scientific consensus.
- ⬤ Extremely Difficult to Access: Rare, experimental, or highly specialized. Requires multiple referrals, long wait times, travel, and strict follow-up.
- ⬤⬤ Difficult to Access: Limited to select centers with moderate barriers. Requires referral, potential travel, and wait times of weeks to months.
- ⬤⬤⬤ Moderately Accessible: Available in larger hospitals or clinics. Requires a basic referral, with moderate wait times and some coordination.
- ⬤⬤⬤⬤ Easy to Access: Widely available in most clinics. Minimal referral, short wait times, and simple preparation or follow-up.
- ⬤⬤⬤⬤⬤ Trivial to Access: Easily found in pharmacies or clinics. No referral needed, minimal wait, and straightforward access.
- ⬤ Up to $100
- ⬤⬤ Up to $500
- ⬤⬤⬤ Up to $2000
- ⬤⬤⬤⬤ Up to $10,000
- ⬤⬤⬤⬤⬤ More than $10,000
To calculate the reported effectiveness for a patient view, the model first analyses whether it can be ascertained that the person writing the review has had direct experience of the treatment for themselves or a loved one. If so, it then uses sentiment analysis to rate their view from 1-5 on how effective this treatment was for them, with 1 being the least effective, and 5 the most effective.
25 Resources
Referenced in this guide
40 Research papers
Referenced in this guide
25 Expert views
Contributed in this guide
32 Patient views
Contributed in this guide
Figure out what Botulinum toxin (BoNT) means for you
Page contents
Basics: What you need to know
Botulinum Neurotoxin Injection Therapy involves carefully injecting highly purified formulations of botulinum toxin into specific muscle groups to ease Parkinson’s-related symptoms like dystonia, tremor, and excessive drooling (sialorrhea). The toxin blocks certain chemical signals, allowing targeted muscle relaxation to reduce involuntary movements. Administered following established neurological guidelines, this therapy is distinct from cosmetic use and is carried out by trained healthcare professionals who tailor the dosage, dilution, and injection sites to each patient’s clinical presentation. While it is especially recognized for muscle relaxation in movement disorders, botulinum toxin also has a range of lesser-known benefits that can indirectly improve a patient’s quality of life, such as decreasing pain linked to muscle tension.
History and development
- Early origins: First identified in the 19th century by Justinus Kerner, botulinum toxin was initially studied for its toxic properties before its therapeutic potential was explored.
- Medical expansion: In the 1970s, Dr. Alan B. Scott began employing botulinum toxin injections for eye muscle disorders, setting the stage for broader neurological uses.
- Neurological protocols: By the 1990s, formal protocols were being established to treat dystonia in Parkinson’s Disease, leading to specialized formulations (like onabotulinumtoxinA and rimabotulinumtoxinB) for different clinical needs.
- Ongoing refinement: Research has continued to refine dosing guidelines, injection sites, and injection intervals for improved outcomes and minimal adverse effects in Parkinson’s Disease.
What is known
- Targeted relief: Precise injections can help reduce muscle rigidity, tremors, and sialorrhea, offering notable improvement in daily activities.
- Well-studied safety: Clinical trials show a generally favorable safety profile when administered according to guidelines, though minor side effects like localized muscle weakness may occur.
- Secondary benefits: Some patients report improved posture, reduced fatigue, and lowered pain levels due to decreased muscle tension.
- Symptom-specific efficacy: Different preparations (e.g., onabotulinumtoxinA vs. rimabotulinumtoxinB) might be more effective for particular Parkinson’s-related symptoms, such as neck dystonia.
- Specialized training: Clinicians must undergo specialized training to properly identify muscles, customize dosage, and avoid adverse effects.
What is not known
- Long-term impact: More research is needed on the long-term effectiveness of repeated injections and the potential for patients to develop resistance.
- Optimal frequency: Although intervals of 3–4 months are common, the exact treatment frequency for best outcomes can vary widely among individuals.
- Complex disease interplay: Parkinson’s Disease is multifaceted, and how botulinum toxin impacts non-motor symptoms like cognition or mood remains less understood.
- Unrecognized benefits: While some data suggests potential benefits beyond movement symptom control, systematic studies are required to confirm these broader effects.
- Chemical blockade: Botulinum toxin prevents nerve cells from releasing acetylcholine, reducing muscle contractions.
- Precise targeting: Specific muscles are pinpointed using clinical assessment or ultrasound, minimizing unwanted spread.
- Symptom reduction: Decreased tremors, rigidity, or excessive drooling by controlling overactive muscles.
- Individualized approach: Dosage, dilution, and injection sites are customized for each patient’s symptoms.
- Mild weakness: Localized muscle weakness can affect fine motor skills.
- Swallowing issues: Injections near the throat can sometimes cause dysphagia.
- Neck discomfort: Some patients report neck pain or stiffness post-injection.
- Dry mouth: Reduced salivation may lead to oral dryness in some individuals.
- Variable response: Some patients get substantial relief, while others see modest improvement.
- Resource-intensive: Trained professionals and repeated visits are needed, raising concerns about cost and accessibility.
- Long-term concerns: Uncertainty exists about reduced effectiveness if neutralizing antibodies develop.
- Optimal usage: Disagreement persists around the best timing, dose intervals, and combination with other therapies.
Patient views
Experiences
- Patients report significant relief from dystonia and muscle spasms, improving daily activities.
- Many find it effective for reducing pain, such as toe cramps and neck rigidity.
- Some describe it as life-changing, restoring functionality and comfort.
- It is often recommended for specific symptoms like foot dystonia or severe cramping.
Challenges
- Some patients experience muscle over-relaxation, leading to issues like difficulty holding up their head.
- The effects are temporary, requiring repeated treatments every few months.
- High costs and insurance challenges deter some patients from continuing.
- A few report no improvement or worsening symptoms, making it ineffective for them.
Tips
- Start with a low dose and adjust gradually for best results.
- Work with a movement disorder specialist for precise injections.
- Be patient; it may take time to find the right dosage and sites.
- Combine Botox with exercises or other therapies for better outcomes.
To calculate the reported effectiveness for a patient view, the model first analyses whether it can be ascertained that the person writing the review has had direct experience of the treatment for themselves or a loved one. If so, it then uses sentiment analysis to rate their view from 1-5 on how effective this treatment was for them, with 1 being the least effective, and 5 the most effective.
Patient view
Yes, I have been using Botox for about a year. Injections are somewhat painful but in the end it does seem to be worth the initial discomfort.
Botox is injected into both of my calf muscles and does help my gait.
May +57110 • Parkinsons News Today
Patient view
If you decide to pursue Botox, temper your expectations to start with because it can take a year or longer to really dial in on the best injection sites and dosages. They generally try to be conservative for obvious reasons.
I get injections for cervical dystonia and also have a shoulder that won't relax, so the MDS does a few injections around there, too (but says the options are more limited). It's been helpful in making me more comfortable but the cyclical nature of the effects wearing off is a little tedious at times. Hopefully it's beneficial to you, OP.
July 2024 • /r/Parkinsons
Expert views
What they liked
- Experts appreciate BoNT's ability to target specific muscles, reducing dystonia and pain.
- BoNT is effective for managing drooling and bladder issues in Parkinson's patients.
- BoNT injections provide relief for dystonic pain and muscle contractions.
- Experts value its temporary effects, allowing dose adjustments every few months.
What they didn't like
- BoNT can cause muscle weakness, affecting daily activities.
- Injections may lead to bruising, infection, or cosmetic concerns.
- Overuse of BoNT can lead to tolerance, reducing effectiveness.
- Rare side effects include difficulty swallowing or urinary retention.
What are they unsure about
- Experts are uncertain about the long-term effectiveness of BoNT.
- Optimal dosing varies widely among individuals, requiring trial and error.
- Experts question its efficacy for widespread dystonia or advanced symptoms.
- Uncertainty exists about BoNT's role in combination with other treatments.
25 expert views
Expert view
Botulinum toxin (BoNT), commonly known as Botox, is used to treat dystonia, a movement disorder that can occur as a symptom of Parkinson's disease. Dr. Kim explains that Botox works by weakening the muscle where it is injected, which can relieve dystonia but may also cause temporary weakness in the treated limb. Finding the right dose often requires trial and error, as it varies between individuals. Other risks include bruising, infection, and cosmetic concerns, especially when injected in sensitive areas like the face. The effects of Botox last about three months, requiring repeated injections. Dr. First notes that Botox is expensive but is usually covered by Medicare and most insurance plans, though approval processes can vary.
September 2018 • Webinar: "Cramping More than Your Style: Dystonia Causes and Care" September 2018
Expert view
Botulinum toxin injections have been found to be effective for treating certain non-motor symptoms of Parkinson's, such as drooling. Clinical studies have demonstrated the benefits and specific dosages for patients, which is exciting progress. This treatment option adds to the limited range of interventions available for non-motor symptoms, which significantly impact the quality of life for Parkinson's patients.
October 2019 • Research and Clinical Trials | Davis Phinney Foundation
What and who it targets
Sialorrhea sufferers
Reduces excessive salivation effectively.
Tremor-dominant Parkinson's
Minimizes involuntary movements.
Focal dystonia patients
Targeted relief for muscle rigidity.
Relevant research
How much evidence on this?
- Substantial evidence from 10+ studies, including meta-analyses.
- Studied for over 30 years, with increasing applications.
- High volume of studies, including systematic reviews and RCTs.
- Consistent findings across motor and non-motor symptoms.
Research focusing on
- Improves tremors, dystonia, and sialorrhea in PD patients.
- Post-treatment care includes monitoring for mild side effects.
- Effective for localized symptoms, less for systemic ones.
- Researchers exploring central effects and new applications.
What needs more research?
- Long-term effects of repeated injections unclear.
- Optimal dosing and injection sites need standardization.
- Mechanisms of central effects in PD remain uncertain.
- Limited data on rare symptoms like epiphora or constipation.
- ⬤ Minimal research: Very little scientific study exists, with no or very few peer-reviewed studies. Insufficient data for conclusions.
- ⬤⬤ Limited research: Few studies exist, mostly small trials or case reports. Findings are preliminary and lack strong validation.
- ⬤⬤⬤ Moderately researched: Multiple studies, including mid-sized trials, exist. Some findings are replicated, but more research is needed.
- ⬤⬤⬤⬤ Well-researched: Supported by substantial evidence, including at least one large trial or meta-analysis.
- ⬤⬤⬤⬤⬤ Extensively studied: Numerous large studies and meta-analyses exist. Findings are widely accepted with strong scientific consensus.
Research
This paper systematically reviewed studies on the effects of Botulinum toxin (BoNT) in Parkinson's disease (PD), focusing on both animal models and human patients. The researchers analyzed evidence from various studies to understand how BoNT might impact motor and non-motor symptoms in PD, particularly through its central mechanisms in the brain.
In animal models of PD, BoNT administered directly into the striatum improved motor and non-motor symptoms without causing neuronal loss, likely due to its anticholinergic effects and influence on compensatory mechanisms related to dopamine deficiency. In humans, limited data showed that BoNT reduced tremor severity and improved measures of sensory-motor integration and intracortical inhibition in PD patients.
For individuals with Parkinson's disease, this research suggests that BoNT might have potential benefits beyond its traditional use for muscle-related symptoms, possibly improving brain function and tremors. However, more studies are needed to confirm these effects and determine how they can be applied in clinical practice.
This paper is a systematic review published in the reputable journal 'Toxins,' which adds credibility. However, the findings rely heavily on animal studies and limited human data, indicating the need for further research to establish stronger evidence.
January 2024 • Toxins
Research
This paper systematically reviewed the effects of botulinum toxin (BoNT) injections on various symptoms associated with Parkinson's disease (PD). Researchers analyzed 41 studies from a pool of over 23,000 articles, focusing on movement disorders, pain, sialorrhea (excessive saliva), and overactive bladder in PD patients.
The review found that BoNT-A significantly improved tremors and dystonia, which are common movement disorders in PD, as well as pain and quality of life. BoNT-A and BoNT-B also reduced saliva production, drooling, and urinary symptoms like urge incontinence. However, freezing of gait (FOG) did not show significant improvement with BoNT treatment.
For individuals with Parkinson's disease, this research highlights how BoNT injections can help manage specific symptoms like tremors, pain, and excessive saliva, potentially improving daily life and comfort. However, it also shows limitations, such as the lack of effectiveness for freezing of gait.
This systematic review is highly reliable due to its adherence to PRISMA guidelines and analysis of 41 studies. Published in the reputable journal Cureus, it provides a comprehensive evaluation of BoNT's role in managing Parkinson's symptoms.
March 2024 • Cureus
Accessibility
- ⬤ Extremely Difficult to Access: Rare, experimental, or highly specialized. Requires multiple referrals, long wait times, travel, and strict follow-up.
- ⬤⬤ Difficult to Access: Limited to select centers with moderate barriers. Requires referral, potential travel, and wait times of weeks to months.
- ⬤⬤⬤ Moderately Accessible: Available in larger hospitals or clinics. Requires a basic referral, with moderate wait times and some coordination.
- ⬤⬤⬤⬤ Easy to Access: Widely available in most clinics. Minimal referral, short wait times, and simple preparation or follow-up.
- ⬤⬤⬤⬤⬤ Trivial to Access: Easily found in pharmacies or clinics. No referral needed, minimal wait, and straightforward access.
- ⬤ Up to $100
- ⬤⬤ Up to $500
- ⬤⬤⬤ Up to $2000
- ⬤⬤⬤⬤ Up to $10,000
- ⬤⬤⬤⬤⬤ More than $10,000
Method to access
- Administered at specialized neurology or movement disorder clinics.
- Requires a prescription and consultation with a neurologist.
- Appointments can be scheduled directly or through referrals.
- Not available for at-home use.
Cost
- Costs range from $375 to $700 per session in the United States.
- In India, costs range from Rs. 5,000 to Rs. 20,000 per session.
- Costs depend on the dosage, brand (e.g., Botox, Dysport), and geographic location.
Insurance cover
- Medicare and private insurance often cover Botulinum toxin for medically necessary conditions like Parkinson's Disease.
- Coverage depends on meeting specific criteria, such as failure of traditional therapies.
- Cosmetic uses are not covered.
Locations
- Mayo Clinic, USA: Renowned for neurology and movement disorder treatments.
- Baylor Medicine, USA: Offers Botulinum toxin for Parkinson's-related symptoms.
- Northwestern Medicine, USA: Specializes in Botulinum injection programs.
- Other specialized neurology clinics worldwide may offer this treatment.
Frequently asked questions
Key resources
More lists
Explore other treatments
It's a lot of information, isn't it?
Turnto's personal AI Assistant can help you figure out what this all means for you
© 2026 Turnto
